Open Access

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

  • Clémentine Gamonet1,
  • Elodie Bole-Richard1,
  • Aurélia Delherme1,
  • François Aubin2,
  • Eric Toussirot2, 3, 4,
  • Francine Garnache-Ottou1, 2,
  • Yann Godet1, 2,
  • Loïc Ysebaert5,
  • Olivier Tournilhac6,
  • Caroline Dartigeas7,
  • Fabrice Larosa1, 8,
  • Eric Deconinck1, 2, 8,
  • Philippe Saas1, 2,
  • Christophe Borg1, 2,
  • Marina Deschamps1 and
  • Christophe Ferrand1, 9Email author
Experimental Hematology & Oncology20165:10

DOI: 10.1186/s40164-016-0038-1

Received: 30 March 2016

Accepted: 30 March 2016

Published: 14 April 2016

The original article was published in Experimental Hematology & Oncology 2016 5:7

Erratum to: Exp Hematol Oncol (2016) 5:7 DOI 10.1186/s40164-016-0036-3

Unfortunately, the original version of this article [1] contained an error. The author Caroline Dartigeas’ name was inverted. The correct presentation is as noted here, Caroline Dartigeas. There will be an update to amend this as well as this erratum.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté
(2)
EA3181 et Service de Dermatologie, Université de Franche Comté, CHU de Besançon
(3)
CHRU, Department of Rheumatology, Université de Franche-Comté EA 4266, INSERM CIC-1431
(4)
EA 4266, Université de Franche-Comté
(5)
Inserm U1037, Université Toulouse 3-ERL CNRS, CHU Purpan
(6)
Hématologie Clinique, CHU Estaing
(7)
Hematologie, CHU Bretonneau
(8)
Hematology Department, CHU Jean Minjoz
(9)
Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang–Bourgogne/Franche-Comté

Reference

  1. Gamonet C, Bole-Richard E, Delherme A, Aubin F, Toussirot E, Garnache-Ottou F, Godet Y, Ysebaert L, Tournilhac O, Dartigeas C, Larosa F, Deconinck E, Saas P, Borg C, Deschamps M, Ferrand C. New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies. Exp Hematol Oncol. 2016;5:7.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Gamonet et al. 2016

Advertisement